stoxline Quote Chart Rank Option Currency Glossary
  
Cosmos Health Inc. (COSM)
0.3833  0.01 (2.71%)    02-13 16:00
Open: 0.3635
High: 0.3999
Volume: 926,256
  
Pre. Close: 0.3732
Low: 0.3635
Market Cap: 10(M)
Technical analysis
2026-02-13 4:43:19 PM
Short term     
Mid term     
Targets 6-month :  0.58 1-year :  0.68
Resists First :  0.49 Second :  0.58
Pivot price 0.45
Supports First :  0.34 Second :  0.28
MAs MA(5) :  0.4 MA(20) :  0.46
MA(100) :  0.68 MA(250) :  0.61
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  14 D(3) :  9.9
RSI RSI(14): 32.3
52-week High :  1.32 Low :  0.28
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ COSM ] has closed above bottom band by 7.6%. Bollinger Bands are 34.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.4 - 0.4 0.4 - 0.41
Low: 0.36 - 0.36 0.36 - 0.36
Close: 0.38 - 0.38 0.38 - 0.39
Company Description

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Headline News

Fri, 13 Feb 2026
Cosmos Health CEO Siokas acquires $145,000 in shares - Investing.com

Thu, 12 Feb 2026
Cosmos Health (COSM) Expands Digital Assets Strategy with Bitcoi - GuruFocus

Wed, 11 Feb 2026
Cosmos Health Inc. Expands Digital Assets Program with $500,000 Investment in Bitcoin - Quiver Quantitative

Wed, 11 Feb 2026
Why a healthcare group is betting $500,000 on Bitcoin after a sell-off - Stock Titan

Wed, 11 Feb 2026
Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies - Sahm

Tue, 20 Jan 2026
Greek drug distributor adds 100 pharmacies, builds robots for $40M potential - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 37 (M)
Shares Float 24 (M)
Held by Insiders 30.1 (%)
Held by Institutions 8 (%)
Shares Short 54 (K)
Shares Short P.Month 138 (K)
Stock Financials
EPS -0.81
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.73
Profit Margin -31.1 %
Operating Margin -10.7 %
Return on Assets (ttm) -13.1 %
Return on Equity (ttm) -63.9 %
Qtrly Rev. Growth 37.9 %
Gross Profit (p.s.) 0.18
Sales Per Share 1.6
EBITDA (p.s.) -0.34
Qtrly Earnings Growth 0 %
Operating Cash Flow -8 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -0.48
PEG Ratio 0
Price to Book value 0.52
Price to Sales 0.23
Price to Cash Flow -1.87
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android